Literature DB >> 22722867

Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells.

Tajie H Harris1, Edward J Banigan, David A Christian, Christoph Konradt, Elia D Tait Wojno, Kazumi Norose, Emma H Wilson, Beena John, Wolfgang Weninger, Andrew D Luster, Andrea J Liu, Christopher A Hunter.   

Abstract

Chemokines have a central role in regulating processes essential to the immune function of T cells, such as their migration within lymphoid tissues and targeting of pathogens in sites of inflammation. Here we track T cells using multi-photon microscopy to demonstrate that the chemokine CXCL10 enhances the ability of CD8+ T cells to control the pathogen Toxoplasma gondii in the brains of chronically infected mice. This chemokine boosts T-cell function in two different ways: it maintains the effector T-cell population in the brain and speeds up the average migration speed without changing the nature of the walk statistics. Notably, these statistics are not Brownian; rather, CD8+ T-cell motility in the brain is well described by a generalized Lévy walk. According to our model, this unexpected feature enables T cells to find rare targets with more than an order of magnitude more efficiency than Brownian random walkers. Thus, CD8+ T-cell behaviour is similar to Lévy strategies reported in organisms ranging from mussels to marine predators and monkeys, and CXCL10 aids T cells in shortening the average time taken to find rare targets.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22722867      PMCID: PMC3387349          DOI: 10.1038/nature11098

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


Toxoplasma gondii is an opportunistic pathogen that causes encephalitis in patients with acquired defects in T cell function[11]. Multiple studies have established that resistance to this parasite in the central nervous system (CNS) relies on T cell production of IFN-γ and cytotoxic T cells, but little is known about the factors that regulate the behavior of effector T cells at this site[12-14]. In order to understand the role of chemokines in directing T cells to regions of infection during toxoplasmic encephalitis (TE), real-time PCR was performed to assess changes in chemokine receptor expression in the brains of infected mice (Supplementary Fig. 1a). Notably, mRNA transcripts for CXCR3, a receptor expressed by activated and memory T cells, and associated with Th1 type responses[15,16] and its ligands, CXCL9 and CXCL10, were highly expressed during TE (Fig. 1a). Previous studies have demonstrated extensive production of cxcl10 mRNA by activated astrocytes during TE[17]. Analysis of lymphocytes isolated from the brains of mice infected with ovalbumin-expressing parasites (PruOVA) revealed that CD8+ T cells, including those specific for ovalbumin, express CXCR3 (Fig. 1b) and migrate towards CXCL10 ex vivo (Fig. 1c). Thus, parasite-specific CD8+ T cells present in the CNS during TE are responsive to CXCR3 ligands.
Figure 1

Chemokine and chemokine receptor expression in the brain during chronic toxoplasmosis

C57BL/6 mice were infected and RNA was isolated from whole brain tissue. Real time PCR specific for cxcl9, cxcl10, and cxcr3 was performed and normalized to hprt mRNA. Results are depicted mean ± s.e.m. of fold increase over uninfected brain. Data is representative of two independent experiments with three mice per group (a). c-d, Brain mononuclear cells (BMNC) were purified on day 35 post-infection. CXCR3 expression (solid line, mean ± s.e.m.) by CD8+ and Kb-SIINFEKL+ (tet+) cells was measured by flow cytometry (c). The gray histogram represents the FMO control. Data is representative of three independent experiments. Purified BMNC were used in ex vivo chemotaxis assays. The mean ± s.e.m. percentage of cells that migrated toward CXCL10 are depicted (d). Results are representative of three independent experiments, n=3.

While CXCL10 is required for resistance to acute T. gondii infection[18], little is known about how this molecule affects T cell responses during chronic TE. Therefore, we treated chronically infected mice with anti-CXCL10 antibodies. One week later, mononuclear cells from the brain were isolated, and T cells were quantified by flow cytometry. Anti-CXCL10 treatment led to a 40% decrease in the number of CD8+ T cells (Fig. 2a, p=0.04) and an increase in parasite burden (Fig. 2b, p=0.04). Immunohistochemical staining for T. gondii revealed latent cyst forms in control mice (Fig. 2c), while regions of active parasite replication were observed in the brains of anti-CXCL10-treated mice (Fig. 2d). To address the role of CXCL10 in the recruitment and maintenance of antigen-specific T cells in the CNS, we used an adoptive transfer system. In vitro activated OVA-specific OT-I cells were transferred to mice chronically infected with PruOVA, resulting in the migration and accumulation of these cells within the CNS[19]. When OT-I T cells were transferred to chronically infected wildtype C57BL/6 or CXCL10-deficient mice, knockout mice had 60% fewer transferred cells in the brain in comparison to wildtype mice, while equivalent numbers were recovered from the spleen and lymph node in both groups (Supplementary Fig. 1b-c). Similar results were obtained when CXCR3-/- and WT OT-I cells were transferred to wildtype mice chronically infected with PruOVA (Supplementary Fig. 1d-e).
Figure 2

CXCL10 affects the CD8+ T cell population and the control of parasite replication

a-b, Mice chronically infected with PruOVA were treated with anti-CXCL10 (+) antibody or control antibody (-). T cells isolated from the brain were identified by flow cytometry (a). Parasite burden was measured in the brain using real time PCR (b). Results are depicted as mean ± s.e.m. of three independent experiments, n=3-4 per group. *p≤0.05, paired student's t-test. c-d, Immunohistochemical staining of brain sections for T. gondii (green), CD8 (red), and DAPI (blue) in anti-CXCL10-treated mice (c) and control animals (d). Size bar = 20μm. OTIGFP cells were expanded in vitro and transferred to mice chronically infected with PruOVA parasites. On day 7 post-transfer, brains from mice that received PBS (con), 300 μg of anti-CXCL10 (anti-CXCL10), or 8 μg pertussis toxin (ptx) i.p. were imaged in 3 dimensions over 10 minutes. Representative cells tracks from control (e), anti-CXCL10 (f), and pertussis-toxin-treated mice (g) are shown (size bars, 100 μm). Volocity software was used to calculate the average track velocity (the average over all cells of the total displacement divided by the total observation time) (h). Cell motility was visualized by plotting individual cell tracks from the origin from control (i), anti-CXCL10-treated (j), and pertussis-toxin-treated (k) mice. **p<0.01, ***p<0.001 by one way ANOVA. Cell track data was obtained from three independent experiments with two mice per group. Control, 12 movies, n=507 cells; anti-CXCL10, 10 movies, n=280 cells; and ptx, 7 movies, n=192 cells.

These studies show that CXCL10 and CXCR3 are required for optimal recruitment and/or retention of antigen-specific CD8+ T cells in the CNS during TE. To determine whether CXCL10 and chemokine signals also affect the migration of CD8+ T cells once they enter the CNS, we used multi-photon (MP) imaging to track GFP-expressing OT-I T cells (OT-IGFP) in explant brain following short-term anti-CXCL10 treatment (Supplementary Movies 1-2). In addition, chemokine signals were inhibited using pertussis toxin, an inhibitor of Gαi signaling[2] (Supplementary Movie 3). We imaged cells for 10-30 minutes since cells migrate out of the field of view during longer imaging periods, biasing our sample towards cells that are less motile. Analysis of the cell tracks (Fig. 2e-g) revealed that anti-CXCL10 treatment reduced the average cell velocity 23% from 6.35 μm/min in control treated mice to 4.88 μm/min (Fig. 2h), while pertussis toxin reduced the track velocity 46% to 3.45 μm/min. Plots of individual cell tracks demonstrate that cells cover less area over a 10-minute time span in the absence of CXCL10 or when treated with pertussis toxin (Fig. 2i-k). We performed a standard analysis to quantitatively determine how chemokines affect the migratory behavior of CD8+ T cells by extracting the motility coefficient (Supplementary Fig. 2). This analysis implicitly assumes a Brownian walk since the motility coefficient is extracted from the slope of the best linear fit to the mean-squared displacement (MSD), 〈r2(t)〉, as a function of time, t[20]. However, when we plot the MSD on a log-log plot, it grows with time approximately as tα, with α≈1.4 (Fig. 3a). This finding suggests that the T cell tracks are not Brownian walks.
Figure 3

CD8+ T cell migration tracks are consistent with generalized Lévy walks

We compare experimental data for cells in control (black circles), anti-CXCL10-treated (green squares), and pertussis toxin-treated (blue triangles) mice with results for the generalized Lévy walk model (solid lines). (a) The mean squared displacement (MSD) grows nonlinearly in time, scaling approximately as t, where α≈1.4 (dashed line). Inset: Linear plot of the MSD. Error bars depict s.e.m. (b) The probability distributions, , of T cell displacements at several different times, t, as indicated in the legend, for cells from control mice only. In order to avoid artifacts[30], histograms were constructed by placing 2500, 2000, 1500, 1300, or 600 displacements in each bin for t=0.37 min, 1.1 min, 2.9 min, 4.8 min, or 9.9 min, respectively. Inset: The displacement probability distributions at different times t collapse onto a single curve when the displacement is scaled by ζ(t). For comparison, a scaled Gaussian distribution is displayed (dashed line). (c) The scale factor, ζ(t), used to rescale displacements in (b) increases approximately as a power law, t, where γ≈0.63. Inset: Normalized displacement correlations, 〈K(τ,t)〉 = 〈r(0,t) · r(τ,τ + t)〉 / 〈r2(0,0)〉, for control cells decay more slowly than exponentially (dashed line) with time τ.

To determine the type of random walk that best describes the migration data, we focused not only on the behavior of the MSD, but also on the shape of the tracks, the probability distribution, , of cell displacements, , as a function of the time interval, t, and the decay of normalized displacement correlations, , as a function of , τ where is the displacement between times τ and τ + t. Together, these properties provide a more complete description of the walk statistics than the MSD alone, and therefore provide far more constraints that must be satisfied by a candidate random walk model. First, by analyzing statistics of the cell trajectory shapes, we established that CD8+ T cells do not exhibit directional migration on the time and length scales relevant to this experiment (see Supplementary Fig. 3 and Supplementary Discussion). To analyze the displacement distribution, we introduced a time-dependent variable, ζ(t) , to scale the cell displacements. For Brownian walks, the distribution, P̃ρ, of scaled displacements, ρ(t)≡ r(t) should be Gaussian, , and the scale factor, ζ(t) , should be the root-mean-squared displacement (RMSD). However, for the migrating CD8+ T cells, the distribution P̃(ρ) is not Gaussian (Fig. 3b, inset); the probability of large displacements is much larger than expected at all times studied. Remarkably, P̃(ρ) has the same shape at all times, indicating that the tracks are also not well described by persistent random walks. Moreover, the scale factor obeys ζ(t) ~ tγ with γ=0.63 , not γ=1/2, as expected for Brownian walks, (Fig. 3c), and clearly differs from the RMSD (Supplementary Fig. 4) at all times studied. Finally, the displacement correlations do not decay exponentially in time, as for Brownian walks (inset to Fig. 3c). Thus, Brownian walks do not describe effector T cell migration during TE. Based on these walk statistics, we considered several variations of Lévy walks (see Supplementary Table 1, Supplementary Fig. 5, and Supplementary Discussion). We find that, consistent with early observations of runs and pauses in lymphocytes[21], T cell migration is well-described by the following model of a generalized Lévy walk[22]. Walkers make straight runs at fixed velocity in random directions over distances chosen randomly from a Lévy distribution, , with μrun=2.15. After each run, a walker pauses for a time whose duration is drawn from a Lévy distribution with μpause=1.7. The values of the exponents μrun and μpause were determined from a maximum likelihood analysis[23] (see Supplementary Discussion). The model captures quantitatively the observed displacement distributions at different times (Fig. 3b), the time evolution of the MSD and scale factor (Fig. 3a and 3c, respectively), the decay of displacement correlations (inset to Fig. 3c), and qualitative features of cell tracks (Supplementary Fig. 6). An Akaike weight analysis[24] indicates that the generalized Lévy walk model does a better job of fitting the displacement distributions than any of the other models we have considered, including, for example, bimodal correlated random walks[25] (see Supplementary Table 1, Supplementary Fig. 5, and Supplementary Discussion). The generalized Lévy walk model is consistent with our data over 30 minutes (Supplementary Figure 7), and also describes the behavior of polyclonal CD8+ T cells, transgenic LCMV-specific CD8+ T cells migrating in the absence of cognate antigen, and CD8+ T cells migrating in the brains of live animals (Supplementary Fig. 8). In the absence of CXCL10 or signals through Gαi-coupled receptors, the migration statistics for CD8+ T cells are well described by the same generalized Lévy walk model, characterized by μrun=2.15 and μpause=1.7 (Supplementary Figs. 6 and 8), as for control cells, but with either a reduced instantaneous speed during runs or longer pauses. Therefore, the chemokine CXCL10 and signals through Gαi-coupled receptors speed up migration without otherwise changing the walk statistics. This result, together with the fact that we find no evidence of directed migration over the time scales investigated (see Supplementary Discussion), suggests a chemokinetic role for CXCL10 during TE. Previous studies have demonstrated that neutrophil or CD8+ T cell control of bacteria or tumor cells, respectively, can be understood by a rate equation in which the killing of targets is modeled as a collision-based process[26,27]. We incorporated the generalized Lévy walk statistics into a similar model to predict the time required to find rare target cells. In our model, we placed N generalized Lévy walkers randomly in a sphere of volume V with a target of radius a at the origin (Supplementary Fig. 9a). We find that cells migrating by generalized Lévy walks are significantly more efficient in finding target cells than those performing Brownian walks (Fig. 4 and Supplementary Fig. 9b-c). Here, the efficiency is the inverse of the sum of the displacements of all the walkers at the instant when the first walker reaches the target[28]. In the absence of CXCL10 or signals through Gαi-coupled receptors, our model predicts that for estimated values of a, V, and N, the capture time for a CD8+ T cell to reach the target is increased by factors of 1.9 or 3.0, respectively, in comparison to the control setting (see Supplementary Fig. 9d-f and Supplementary Discussion). These results suggest that the ability of CD8+ T cells to find and control T. gondii-infected targets in the CNS is aided by a generalized Lévy walk search strategy, and the capture time is shortened by CXCL10, and likely by other chemokines as well. We emphasize that the generalized Lévy walk is not necessarily an optimal search strategy, and a model with μrun=2.0 would be more efficient according to this definition[28]. Moreover, the efficiency is highly dependent on details of the environment and search/capture process[29] that are not presently known, so determination of the optimal search strategy remains an open question.
Figure 4

Generalized Lévy walks find targets more efficiently than random walks

We determined efficiency for generalized Lévy walkers (black circles) and Brownian walkers (open red squares) as a function of the target radius, a. The generalized Lévy search is considerably more efficient, especially when the targets are small. Error bars are the s.e.m. Examples of trajectories for Brownian walks (small inset) and the generalized Lévy walk model (large inset) are shown.

Lévy search strategies may be used by diverse species, including microzooplankton, fruit flies, honey bees, mussels, predatory fish, sea turtles, penguins, and spider monkeys[4-10]. Our results show that a generalization of this search strategy appears to be relevant, at the single cell level, to the ability of effector cells to find rare targets. In addition, our findings provide a novel insight into the role of CXCL10 as a chemokine that specifically influences the capture time for CD8+ T cells to find infected targets during toxoplasmic encephalitis. Altogether, our findings raise several fundamental questions as to whether lymphocytes execute generalized Lévy walks in other environments, how activation status affects walk statistics, and whether the pauses suggested by our model arise from factors internal to the cell or from interactions of the cells with their external environment.

Methods Summary

T. gondii infection was established by intraperitoneal injection of ovalbumin-expressing Prugnauid strain (PruOVA) tachyzoites. Real time PCR was performed for chemokine receptor expression and T. gondii DNA quantification. Brain mononuclear cells were stained with fluorescently conjugated antibodies for flow cytometric analysis. OT-I cells were activated in vitro and transferred to recipient mice. Mice were treated with four doses of 100 μg of anti-CXCL10 for week-long depletion studies or 300 μg 18 hours prior to imaging studies. Pertussis toxin was administered at 400 μg/kg six hours before imaging. For MP microscopy, explant brain was imaged using a Leica SP5 2-photon microscopy system. Cell tracking was performed using Volocity software. In order to create displacement histograms without binning artifacts[30] (Supplementary Tables 2-3), a constant number of displacements were placed in each bin. Various statistical methods were applied to test the validity of the generalized Lévy walk model (see Fig. 3, Supplementary Figs. 3, 5, 7, 8, 10, Supplementary Table 1, and Supplementary Discussion). Brownian dynamics-like simulations were performed to simulate the general behavior and searching capability of Gaussian (“random”) and Lévy walkers (see Supplementary Discussion). N searchers were placed in a spherical volume of radius b, and they moved stochastically until finding the target of radius a, which was stationary at the center of the sphere. During random walks, searchers moved 6DΔt = 0.1μm in the x-, y-, or z-direction each time step; here D is the motility coefficient and Δt is the time step. In Lévy walk simulations, a direction for a run was chosen at random, and run lengths were drawn from a Lévy distribution with exponent μrun=2.15. Searchers moved a distance vΔt each time step until the run was completed. After each run, the walker paused for a time drawn from Lévy distribution with μpause=1.7.
  32 in total

1.  Two-photon imaging of lymphocyte motility and antigen response in intact lymph node.

Authors:  Mark J Miller; Sindy H Wei; Ian Parker; Michael D Cahalan
Journal:  Science       Date:  2002-05-16       Impact factor: 47.728

2.  Optimizing the success of random searches.

Authors:  G M Viswanathan; S V Buldyrev; S Havlin; M G da Luz; E P Raposo; H E Stanley
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

Review 3.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.

Authors:  Jason G Cyster
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Model selection in ecology and evolution.

Authors:  Jerald B Johnson; Kristian S Omland
Journal:  Trends Ecol Evol       Date:  2004-02       Impact factor: 17.712

5.  Laminar-localized-phase coexistence in dynamical systems.

Authors: 
Journal:  Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics       Date:  1995-03

6.  Lévy walks evolve through interaction between movement and environmental complexity.

Authors:  Monique de Jager; Franz J Weissing; Peter M J Herman; Bart A Nolet; Johan van de Koppel
Journal:  Science       Date:  2011-06-24       Impact factor: 47.728

Review 7.  Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues.

Authors:  Lisa M Ebert; Patrick Schaerli; Bernhard Moser
Journal:  Mol Immunol       Date:  2004-11-23       Impact factor: 4.407

Review 8.  Toxoplasmosis.

Authors:  J G Montoya; O Liesenfeld
Journal:  Lancet       Date:  2004-06-12       Impact factor: 79.321

9.  Behavior of parasite-specific effector CD8+ T cells in the brain and visualization of a kinesis-associated system of reticular fibers.

Authors:  Emma H Wilson; Tajie H Harris; Paulus Mrass; Beena John; Elia D Tait; Gregory F Wu; Marion Pepper; E John Wherry; Florence Dzierzinski; David Roos; Philip G Haydon; Terri M Laufer; Wolfgang Weninger; Christopher A Hunter
Journal:  Immunity       Date:  2009-01-22       Impact factor: 31.745

10.  Determination of the critical concentration of neutrophils required to block bacterial growth in tissues.

Authors:  Yongmei Li; Arthur Karlin; John D Loike; Samuel C Silverstein
Journal:  J Exp Med       Date:  2004-09-06       Impact factor: 14.307

View more
  188 in total

1.  Extending Lévy search theory from one to higher dimensions: Lévy walking favours the blind.

Authors:  A M Reynolds
Journal:  Proc Math Phys Eng Sci       Date:  2015-07-08       Impact factor: 2.704

2.  Parasites: what are they good for?

Authors:  Jason S Stumhofer; P'ng Loke
Journal:  Curr Immunol Rev       Date:  2013-08-01

3.  Antibody Neutralization of CXCL10 in Vivo Is Dependent on Binding to Free and Not Endothelial-bound Chemokine: IMPLICATIONS FOR THE DESIGN OF A NEW GENERATION OF ANTI-CHEMOKINE THERAPEUTIC ANTIBODIES.

Authors:  Pauline Bonvin; Franck Gueneau; Vanessa Buatois; Maud Charreton-Galby; Stanley Lasch; Marie Messmer; Urs Christen; Andrew D Luster; Zoë Johnson; Walter Ferlin; Marie Kosco-Vilbois; Amanda Proudfoot; Nicolas Fischer
Journal:  J Biol Chem       Date:  2017-01-30       Impact factor: 5.157

4.  Lévy flight movement patterns in marine predators may derive from turbulence cues.

Authors:  A M Reynolds
Journal:  Proc Math Phys Eng Sci       Date:  2014-11-08       Impact factor: 2.704

Review 5.  Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy.

Authors:  Joseph G Crompton; Madhusudhanan Sukumar; Nicholas P Restifo
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

6.  CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Authors:  Mehdi Rashighi; Priti Agarwal; Jillian M Richmond; Tajie H Harris; Karen Dresser; Ming-Wan Su; Youwen Zhou; April Deng; Christopher A Hunter; Andrew D Luster; John E Harris
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

7.  "Cell biology meets physiology: functional organization of vertebrate plasma membranes"--the immunological synapse.

Authors:  Silvia Curado; Sudha Kumari; Michael L Dustin
Journal:  Curr Top Membr       Date:  2013       Impact factor: 3.049

8.  CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells.

Authors:  Heather D Hickman; Glennys V Reynoso; Barbara F Ngudiankama; Stephanie S Cush; James Gibbs; Jack R Bennink; Jonathan W Yewdell
Journal:  Immunity       Date:  2015-03-10       Impact factor: 31.745

9.  Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system.

Authors:  Christoph Konradt; Norikiyo Ueno; David A Christian; Jonathan H Delong; Gretchen Harms Pritchard; Jasmin Herz; David J Bzik; Anita A Koshy; Dorian B McGavern; Melissa B Lodoen; Christopher A Hunter
Journal:  Nat Microbiol       Date:  2016-02-15       Impact factor: 17.745

10.  Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies.

Authors:  Marco Ruella; David M Barrett; Saad S Kenderian; Olga Shestova; Ted J Hofmann; Jessica Perazzelli; Michael Klichinsky; Vania Aikawa; Farzana Nazimuddin; Miroslaw Kozlowski; John Scholler; Simon F Lacey; Jan J Melenhorst; Jennifer J D Morrissette; David A Christian; Christopher A Hunter; Michael Kalos; David L Porter; Carl H June; Stephan A Grupp; Saar Gill
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.